Soluble (pro)renin receptor increased by hypoxia maintains oxidative metabolism in trophoblasts

J Mol Endocrinol. 2020 Apr;64(3):145-154. doi: 10.1530/JME-19-0050.

Abstract

Elevated soluble (pro)renin receptor (s(P)RR) concentration in maternal blood is associated with gestational hypertension and preeclampsia. Placenta has abundant expression of (P)RR, and the binding of (P)RR with pyruvate dehydrogenase E1 beta subunit (PDHB) is reported to maintain oxidative metabolism. Thus, we hypothesized that placental hypoxia may increase (P)RR, and the increased (P)RR may preserve PDHB expression. Expression and functional analyses were performed using human placental trophoblast cells, mainly JAR cells. (P)RR co-immunoprecipitated and showed co-immunofluorescence with PDHB mainly in the mitochondria. Hypoxia treatment significantly increased intracellular s(P)RR protein expression, but secreted s(P)RR in the culture medium was decreased by hypoxia. Hypoxia treatment did not alter PDHB expression or activity in the basal condition, but when (P)RR was knocked down by siRNA, PDHB protein and activity were reduced by hypoxia. Acetyl-CoA, the product of PDH activity, was significantly reduced by hypoxia treatment with (P)RR siRNA. S(P)RR is generated from full-length PRR when cleaved by specific proteases. Protease inhibitor experiments suggested furin and site 1 protease as the enzymes generating s(P)RR in JAR cells, and only when treated by site 1 protease inhibitor, PF429242, PDHB protein showed a significant trend to decrease with hypoxia. In JAR cells, hypoxia increased intracellular s(P)RR, and (P)RR preserved the expression and function of PDHB during hypoxia. (P)RR may help maintain oxidative metabolism and efficient energy production during placental ischemia in hypertensive disorders of pregnancy.

Keywords: ischemia; placenta; preeclampsia; renin-angiotensin-aldosterone system.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Hypoxia / drug effects
  • Cell Hypoxia / genetics*
  • Cell Respiration / drug effects
  • Cell Respiration / genetics
  • Cells, Cultured
  • Female
  • Humans
  • Oxidative Phosphorylation / drug effects
  • Oxidative Stress / drug effects
  • Oxidative Stress / genetics*
  • Oxygen / metabolism
  • Oxygen / pharmacology
  • Pregnancy
  • Pyruvate Dehydrogenase (Lipoamide) / genetics
  • Pyruvate Dehydrogenase (Lipoamide) / metabolism
  • Receptors, Cell Surface / genetics
  • Receptors, Cell Surface / metabolism
  • Receptors, Cell Surface / physiology*
  • Solubility
  • Trophoblasts / drug effects
  • Trophoblasts / metabolism*
  • Up-Regulation / drug effects
  • Up-Regulation / genetics
  • Vacuolar Proton-Translocating ATPases / genetics
  • Vacuolar Proton-Translocating ATPases / metabolism
  • Vacuolar Proton-Translocating ATPases / physiology*

Substances

  • ATP6AP2 protein, human
  • Receptors, Cell Surface
  • Pyruvate Dehydrogenase (Lipoamide)
  • pyruvate dehydrogenase E1 beta subunit
  • Vacuolar Proton-Translocating ATPases
  • Oxygen